Long-Range Epigenetic Silencing Associates with Deregulation of Ikaros Targets in Colorectal Cancer Cells

Transcription factors are common targets of epigenetic inactivation in human cancer. Promoter hypermethylation and subsequent silencing of transcription factors can lead to further deregulation of their targets. In this study, we explored the potential epigenetic deregulation in cancer of Ikaros family genes, which code for essential transcription factors in cell differentiation and exhibit genetic defects in hematologic neoplasias. Unexpectedly, our analysis revealed that Ikaros undergoes very specific promoter hypermethylation in colorectal cancer, including in all the cell lines studied and around 64% of primary colorectal adenocarcinomas, with increasing proportions in advanced Duke's stages. Ikaros hypermethylation occurred in the context of a novel long-range epigenetic silencing (LRES) region. Reintroduction of Ikaros in colorectal cancer cells, ChIP-chip analysis, and validation in primary samples led us to identify a number of direct targets that are possibly related with colorectal cancer progression. Our results not only provide the first evidence that LRES can have functional specific effects in cancer but also identify several deregulated Ikaros targets that may contribute to progression in colorectal adenocarcinoma. Mol Cancer Res; 9(8); 1139–51. ©2011 AACR.

[1]  Lijun Liu,et al.  The function of the protein tyrosine phosphatase SHP-1 in cancer. , 2003, Gene.

[2]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[3]  R. Green,et al.  Comparison of sample preparation methods for ChIP-chip assays. , 2006, BioTechniques.

[4]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[5]  K. Georgopoulos,et al.  Control of lymphocyte development by the Ikaros gene family. , 1999, Current opinion in immunology.

[6]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[7]  V. Moreno,et al.  Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease , 2009, British Journal of Cancer.

[8]  Katie L. Kathrein,et al.  Ikaros Directly Represses the Notch Target Gene Hes1 in a Leukemia T Cell Line , 2008, Journal of Biological Chemistry.

[9]  P. Stanier,et al.  Reciprocal imprinting of human GRB10 in placental trophoblast and brain: evolutionary conservation of reversed allelic expression. , 2009, Human molecular genetics.

[10]  Clare Stirzaker,et al.  Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band , 2006, Nature Genetics.

[11]  K. Georgopoulos,et al.  Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes , 1999, The EMBO journal.

[12]  Susan J Clark,et al.  Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. , 2007, Human molecular genetics.

[13]  Christopher B. Miller,et al.  BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros , 2008, Nature.

[14]  Mark D. Robinson,et al.  Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity , 2010, Nature Cell Biology.

[15]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[16]  K. Washington,et al.  DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett’s adenocarcinoma , 2008, Gut.

[17]  Christopher B. Miller,et al.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. , 2009, The New England journal of medicine.

[18]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Zohar Yakhini,et al.  Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.

[20]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[21]  S. Brenner,et al.  STAT4 is a target of the hematopoietic zinc‐finger transcription factor Ikaros in T cells , 2005, FEBS letters.

[22]  N. Copeland,et al.  Identification of a new family of Pbx-related homeobox genes. , 1996, Oncogene.

[23]  P. Laird,et al.  Epigenetic stem cell signature in cancer , 2007, Nature Genetics.

[24]  Jose Russo,et al.  Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. , 2010, Genome research.

[25]  I. Simon,et al.  Evidence for an instructive mechanism of de novo methylation in cancer cells , 2006, Nature Genetics.

[26]  S. Smale,et al.  Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. , 2001, Genes & development.

[27]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[28]  Kathy Pritchard-Jones,et al.  Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor , 2009, PLoS genetics.